Hypothalalmic inflammation disrupts energy homeostasis by leading to pathogenic changes in insulin signaling, feeding and body weight and thus is a major target for the prevention and treatment of various metabolic diseases including DIO and T2DM. Here, INS is linked to type 2 diabetes mellitus.